Neurogenic Orthostatic Hypotension &Ndash; Management Update and Role of Droxidopa

Therapeutics and Clinical Risk Management

doi 10.2147/tcrm.s68439

Full Text

Abstract

Available in

Date

June 1, 2015

Authors

Publisher

Informa UK Limited

Related search

Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension

American Journal of Cardiology

Cardiovascular Medicine

English

Adjusting Droxidopa for Neurogenic Orthostatic Hypotension in a Patient With Parkinson Disease

Clinical Autonomic Research

Autonomic Systems

English

Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension

Movement Disorders Clinical Practice

English

Defining Successful Treatment of Neurogenic Orthostatic Hypotension With Droxidopa in a Patient With Multiple System Atrophy

Clinical Autonomic Research

Autonomic Systems

English

A Practical Guide to the Treatment of Neurogenic Orthostatic Hypotension

Canadian Journal of Neurological Sciences

English

Functional Effects of Cardiac Sympathetic Denervation in Neurogenic Orthostatic Hypotension

Parkinsonism and Related Disorders

English

Metastatic Paraganglioma: Management of Orthostatic Hypotension – A Case Report

JRSM Cardiovascular Disease

English

Review of Management Strategies for Orthostatic Hypotension in Older People

Journal of Pharmacy Practice and Research

English

Drug-Induced Orthostatic Hypotension

Clinical pharmacology and therapy

English